← Current compounder rows

Current NDC auxiliary source row compounder:3885

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source
ndc_compounder_zip
Product Ndc Raw
73702-109
Product Ndc
73702-109
Product Ndc Digits
73702109
Product Type Name
HUMAN COMPOUNDED DRUG
Proprietary Name
Glycopyrrolate
Proprietary Name Suffix
[empty]
Nonproprietary Name
Glycopyrrolate
Dosage Form Name
INJECTION
Route Name
INTRAMUSCULAR; INTRAVENOUS
Marketing Category Name
OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name
Wells Pharma of Houston
Establishment Name
Wells Pharma of Houston
Establishment Fei
[empty]
Substance Name
GLYCOPYRROLATE
Active Ingredients Info
.2 mg/1 mL
History Active Ingredients Raw
GLYCOPYRROLATE
History Active Ingredients Info Raw
.2 mg/1 mL
History Dosage Raw
INJECTION
Dea Schedule
[empty]
Package Ndc Raw
73702-109-15
Package Ndc
73702-109-15
Package Ndc Digits
7370210915
Package Ndc11
73702010915
Package Description
5 mL in 1 SYRINGE (73702-109-15)
Reporting Period Raw
2025-1
Reporting Period
2025-1
Normalization Status
valid
Source Url
https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive
compounders_ndc_directory.zip
Source File
compounders_ndc_directory.txt
Source Date
2026-09-18
Source Last Modified
Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256
222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256
f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id
compounder:3885
Source Row Number
3885
Source Row Hash
270ebf438ceecf8350e87d3d13603d5809b24ce4ce4268507fc8773f39525bde
Import Run Id
20261116T204628Z
Loaded At
2026-11-16 20:58:00

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRAMUSCULAR; INTRAVENOUS",
    "PRODUCTNDC": "73702-109",
    "DEASCHEDULE": "",
    "LABELERNAME": "Wells Pharma of Houston",
    "SUBSTANCENAME": "GLYCOPYRROLATE",
    "DOSAGEFORMNAME": "INJECTION",
    "NDCPACKAGECODE": "73702-109-15",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Glycopyrrolate",
    "REPORTINGPERIOD": "2025-1",
    "NONPROPRIETARYNAME": "Glycopyrrolate",
    "PACKAGEDESCRIPTION": "5 mL in 1 SYRINGE (73702-109-15) ",
    "ACTIVEINGREDIENTSINFO": ".2 mg/1 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset
compounder
Record Source
ndc_compounder_zip
Source Record Id
compounder:3885
Source Row Number
3885
Status Scope
package
Lookup Ndc
73702-109-15
Lookup Ndc Digits
7370210915
Product Ndc
73702-109
Product Ndc Digits
73702109
Package Ndc
73702-109-15
Package Ndc Digits
7370210915
Package Ndc11
73702010915
Product Id
[empty]
Status Code
COMPOUNDER
Status Label
Outsourcing facility compounded drug report
Reporting Period Raw
2025-1
Reporting Period
2025-1
Source Table
fda_ndc_aux_compounder
Source File
compounders_ndc_directory.txt
Source Date
2026-09-18
Source Row Hash
270ebf438ceecf8350e87d3d13603d5809b24ce4ce4268507fc8773f39525bde
Import Run Id
20261116T204628Z
Loaded At
2026-11-16 20:58:00